Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The Rapid Diagnostics market size is projected to reach a CAGR of 11.6% from 2022 to 2028.
Rapid Diagnostics are the medical techniques which are used for the diagnosis and the detection of the disease but are way to perform and are quick. These techniques play major role in the situation wherein the preliminary or the emergency situation similar to the ongoing pandemic. These test kits tend to provide the results in either 20 minutes or the same day.
The technological advancements in the sector along with the surge in the incidents of the infectious disease are some of the factors that have supported long-term expansion for Rapid Diagnostics Market.
COVID-19 had a positive effect on the market, as because the global demand has increased to various folds and also the shortage of lab-based testing facilities the demand for rapid diagnostics was increased.
North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the incidents of lifestyle disorder becoming popular in the region and also the presence of the key players in the region.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 11.6% during the forecasting period, 2022-2028 |
Historical Data |
2019-2020 |
Forecast Years |
2022-2028 |
Base Year |
2021 |
Units Considered |
Revenue in USD billion and CAGR from 2022 to 2028 |
Report Segmentation |
product, platform, mode of purchase, end users and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Roche Diagnostics , Siemens Healthineers , Danaher Corporation , Becton Dickinson and Company , Abbott Laboratories , Quidel Diagnostics , and Chembio Diagnostics EKF Diagnostics , Trinity Biotech , and Fluxergy |
Available Customization |
In addition to the market data for Rapid Diagnostics Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Rapid Diagnostics Market is segmented into product, platform, mode of purchase, end users and region.